A Phase 3 Trial of ADXS11-001 (NSC #752718) Administered

Project: Research project

Description

A Phase 3 Trial of ADXS11-001 (NSC #752718) Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
StatusActive
Effective start/end date9/1/168/31/20

Funding

  • ADVAXIS, INC.

Fingerprint

Uterine Cervical Neoplasms